- Vanishing Cream Formula
- Fight Acne-Causing Bacteria While Gentle on Skin
- Benzoyl Peroxide Acne Medication
- Clinically Proven Power
- Tough on Acne, Easy on Your Skin
- Dermatologist Recommended
- Absorbs Quickly, Work Invisibly
Some medicated sport treatments contain 10% benzoyl peroxide that can irritate skin, causing redness and dryness which can make acne worse. Neutrogena On-the-Spot Acne Treatment is clinically proven to be strong and effective in fighting acne while gentle on skin.
Clinically Proven Effectiveness With No Burning’ Won’t Dry Out Skin
Neutrogena On-the-Spot Acne Treatment contains just 2.5% benzoyl peroxide, yet is clinically proven to be so effective that skin starts getting clearer on day 1 – all without over-drying, stinging or burning skin. This fast working formula is so lightweight that it quickly absorbs into skin. It goes deep down in the pores to kill the acne bacteria that cause pimples and helps to prevent new ones from forming.
 Works Hard Hour After Hour To Keep Skin Healthy-Looking
Helps relieve redness of acne pimples without over-drying skin. Long-lasting protection. Works hour after hour to treat acne all day long.
Use –Â For the treatment of acne.
Active ingredient | Purpose |
Benzoyl Peroxide 2.5% | Acne Medication |
Inactive ingredient: Water, carbomer homopolymer, type b, ethylhexylglycerin, sodium hydroxide, chlorphenesin, disodium edta, laureth-4, hydroxypropyl methylcellulose. |
Suggested use
- Clean the skin thoroughly before applying this product.
- Cover the entire affected area within a thin layer one to three times daily.
- Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor.
- If bothersome dryness or peeling occurs, reduce application to once a day or every other day.
- If going outside, apply sunscreen after using this product. If irritation or sensitivity develops, stop use of both products and ask a doctor.
Reviews
There are no reviews yet.